All Outputs (5)

Provider‐related barriers and enablers to the provision of hepatitis C treatment by General Practitioners in Scotland: A behaviour change analysis (2020)
Journal Article
Whiteley, D., Speakman, E., Elliott, L., Davidson, K., Hamilton, E., Jarvis, H., …Flowers, P. (2021). Provider‐related barriers and enablers to the provision of hepatitis C treatment by General Practitioners in Scotland: A behaviour change analysis. Journal of Viral Hepatitis, 28(3), 528-537. https://doi.org/10.1111/jvh.13443

The ease of Direct Acting Antiviral (DAA) medications for hepatitis C virus (HCV) has provided an opportunity to decentralise HCV treatment into community settings. However, the role of non-specialist clinicians in community-based pathways has recei... Read More about Provider‐related barriers and enablers to the provision of hepatitis C treatment by General Practitioners in Scotland: A behaviour change analysis.

Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol) (2019)
Journal Article
Hickman, M., Dillon, J. F., Elliott, L., De Angelis, D., Vickerman, P., Foster, G., …Hutchinson, S. J. (2019). Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol). BMJ Open, 9(9), Article e029538. https://doi.org/10.1136/bmjopen-2019-029538

Hepatitis C virus (HCV) is the second largest contributor to liver disease in the UK, with injecting drug use as the main risk factor among the estimated 200 000 people currently infected. Despite effective prevention interventions, chronic HCV preva... Read More about Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol).

Hepatitis C in a new therapeutic era: Recontextualising the lived experience (2017)
Journal Article
Whiteley, D., Whittaker, A., Elliott, L., & Cunningham-Burley, S. (2017). Hepatitis C in a new therapeutic era: Recontextualising the lived experience. Journal of Clinical Nursing, https://doi.org/10.1111/jocn.14083

Aims and Objectives To explore the experience of adults living with hepatitis C in a new era of interferon-free treatment. Background Hepatitis C is a leading cause of morbidity and mortality worldwide, posing a significant challenge to global pub... Read More about Hepatitis C in a new therapeutic era: Recontextualising the lived experience.

The lived experience of interferon-free treatments for hepatitis C: A thematic analysis (2016)
Journal Article
Whiteley, D., Whittaker, A., Elliott, L., & Cunningham-Burley, S. (2016). The lived experience of interferon-free treatments for hepatitis C: A thematic analysis. International Journal of Drug Policy, 38, 21-28. https://doi.org/10.1016/j.drugpo.2016.10.013

Background: International discourse concerning the evolution in hepatitis C virus (HCV) therapy has tended to focus on improving outcomes, shortened treatment length and reduced side-effects of interferon-free regimens. How these treatments are being... Read More about The lived experience of interferon-free treatments for hepatitis C: A thematic analysis.

Health-Related Quality of Life for individuals with hepatitis C: A narrative review (2015)
Journal Article
Whiteley, D., Elliott, L., Cunningham-Burley, S., & Whittaker, A. (2015). Health-Related Quality of Life for individuals with hepatitis C: A narrative review. International Journal of Drug Policy, 26(10), 936-949. https://doi.org/10.1016/j.drugpo.2015.04.019

BACKGROUND The assessment of Health-Related Quality of Life (HRQoL) in hepatitis C (HCV) infected individuals continues to gain importance. However, rarely do reviews of this literature consider quantitative and qualitative accounts of HRQoL colle... Read More about Health-Related Quality of Life for individuals with hepatitis C: A narrative review.